Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 16.51 USD 0.61% Market Closed
Market Cap: 2.4B USD

Wall Street
Price Targets

DNLI Price Targets Summary
Denali Therapeutics Inc

Wall Street analysts forecast DNLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNLI is 32.48 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Lowest
Price Target
24.24 USD
47% Upside
Average
Price Target
32.48 USD
97% Upside
Highest
Price Target
42 USD
154% Upside
Denali Therapeutics Inc Competitors:
Price Targets
CPRX
Catalyst Pharmaceuticals Inc
51% Upside
ASMB
Assembly Biosciences Inc
43% Upside
CRSP
CRISPR Therapeutics AG
53% Upside
688180
Shanghai Junshi Biosciences Co Ltd
22% Downside
XNCR
Xencor Inc
88% Upside
QTTB
Homology Medicines Inc
248% Upside
ZEAL
Zealand Pharma A/S
60% Upside
9926
Akeso Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DNLI's stock price target?
Price Target
32.48 USD

According to Wall Street analysts, the average 1-year price target for DNLI is 32.48 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Back to Top